KRTAP19-8
gene geneOn this page
Summary
KRTAP19-8 (keratin associated protein 19-8, HGNC:33898) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 19-8 (Q3LI54). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to be located in cytosol.
Source: NCBI Gene 728299 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 13 total
- MANE Select transcript:
NM_001099219
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33898 |
| Approved symbol | KRTAP19-8 |
| Name | keratin associated protein 19-8 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000206102 |
| Ensembl biotype | protein_coding |
| Entrez | 728299 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000382822
RefSeq mRNA: 1 — MANE Select: NM_001099219
NM_001099219
CCDS: CCDS42917
Canonical transcript exons
ENST00000382822 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001493459 | 31038159 | 31038476 |
Expression profiles
Bgee: expression breadth broad, 53 present calls, max score 93.68.
Top tissues by expression
100 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 93.68 | gold quality |
| granulocyte | CL:0000094 | 47.50 | silver quality |
| right testis | UBERON:0004534 | 42.74 | gold quality |
| testis | UBERON:0000473 | 37.28 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| left testis | UBERON:0004533 | 37.15 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| bone marrow | UBERON:0002371 | 33.91 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| urinary bladder | UBERON:0001255 | 32.57 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| right lung | UBERON:0002167 | 30.76 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.87 | gold quality |
| liver | UBERON:0002107 | 29.61 | silver quality |
| leukocyte | CL:0000738 | 29.58 | gold quality |
| islet of Langerhans | UBERON:0000006 | 29.13 | gold quality |
| monocyte | CL:0000576 | 28.75 | gold quality |
| adenohypophysis | UBERON:0002196 | 28.27 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| uterine cervix | UBERON:0000002 | 27.34 | gold quality |
| ectocervix | UBERON:0012249 | 27.07 | silver quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.46 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 19-8 — Q3LI54 (reviewed: Q3LI54)
All UniProt accessions (1): Q3LI54
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 19 family.
RefSeq proteins (1): NP_001092689* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR021743 | KRTAP_type8/19/20/21/22 | Family |
| IPR051528 | KRTAP_type_19 | Family |
Pfam: PF11759
UniProt features (2 total): chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3LI54-F1 | 51.48 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 12 (showing top):
MARTINEZ_RB1_TARGETS_DN, chr21q22, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, CHEN_METABOLIC_SYNDROM_NETWORK, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, SRSF9_TARGET_GENES, MARTINEZ_RB1_AND_TP53_TARGETS_DN, MARTINEZ_TP53_TARGETS_DN, GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
112 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP19-8 | OR1N1 | Q8NGS0 | 666 |
| KRTAP19-8 | OR56A3 | Q8NH54 | 621 |
| KRTAP19-8 | OR8B12 | Q8NGG6 | 609 |
| KRTAP19-8 | OR5M10 | Q6IEU7 | 608 |
| KRTAP19-8 | OR5L2 | Q8NGL0 | 581 |
| KRTAP19-8 | KRTAP5-7 | Q6L8G8 | 580 |
| KRTAP19-8 | KRTAP20-2 | Q3LI61 | 577 |
| KRTAP19-8 | OR51V1 | Q9H2C8 | 571 |
| KRTAP19-8 | OR5L1 | Q8NGL2 | 541 |
| KRTAP19-8 | KNOP1 | Q1ED39 | 517 |
| KRTAP19-8 | OR4N4 | Q8N0Y3 | 511 |
| KRTAP19-8 | KRTAP5-11 | Q6L8G4 | 506 |
| KRTAP19-8 | KRTAP5-5 | Q701N2 | 506 |
| KRTAP19-8 | OR2M5 | A3KFT3 | 474 |
| KRTAP19-8 | RPUSD3 | Q6P087 | 446 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: H2A0M6, O08632, O08633, O08640, P02448, P04459, P05685, P08826, P25692, P82170, P83358, Q02957, Q02958, Q28580, Q3LHN2, Q3LI54, Q3LI58, Q3LI59, Q3LI60, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI68, Q3LI70, Q3LI72, Q3LI73, Q3LI77, Q3MIV0, Q3SYF9, Q4W7G7, Q4W7G8, Q4W7G9, Q4W7H0, Q4W7H1, Q6F4C6, Q6R645, Q7Z4W3, Q8C1I6
Diamond homologs: Q3LI54, Q3SYF9, Q925H7, Q3LI72, Q3LI73, Q7Z4W3, Q925H6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
13 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 12 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
117 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:31038275:AT:A | donor_gain | 0.8900 |
| 21:31038426:G:C | donor_gain | 0.8800 |
| 21:31038417:T:TA | donor_gain | 0.8700 |
| 21:31038275:ATCCT:A | donor_gain | 0.8400 |
| 21:31038279:T:TA | donor_gain | 0.8400 |
| 21:31038438:G:C | donor_gain | 0.8400 |
| 21:31038396:T:TA | donor_gain | 0.8100 |
| 21:31038385:C:CT | donor_gain | 0.7900 |
| 21:31038412:AGG:A | donor_gain | 0.7900 |
| 21:31038429:T:TA | donor_gain | 0.7700 |
| 21:31038252:T:TA | donor_gain | 0.7600 |
| 21:31038276:T:TA | donor_gain | 0.7600 |
| 21:31038402:G:C | donor_gain | 0.7400 |
| 21:31038314:AG:A | donor_gain | 0.7300 |
| 21:31038401:AG:A | donor_gain | 0.7300 |
| 21:31038276:T:C | donor_gain | 0.7200 |
| 21:31038391:AAG:A | donor_gain | 0.7200 |
| 21:31038407:AG:A | donor_gain | 0.6600 |
| 21:31038318:T:TA | donor_gain | 0.6300 |
| 21:31038386:C:CT | donor_gain | 0.6200 |
| 21:31038408:G:C | donor_gain | 0.6100 |
| 21:31038443:T:C | donor_gain | 0.6100 |
| 21:31038340:A:T | donor_gain | 0.5400 |
| 21:31038314:AGCCT:A | donor_gain | 0.5300 |
| 21:31038280:C:CA | donor_gain | 0.5200 |
| 21:31038407:AGC:A | donor_gain | 0.5200 |
| 21:31038248:CT:C | donor_gain | 0.5000 |
| 21:31038188:C:CC | acceptor_gain | 0.4900 |
| 21:31038186:ACC:A | acceptor_loss | 0.4700 |
| 21:31038187:CCTG:C | acceptor_loss | 0.4700 |
AlphaMissense
385 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:31038267:G:C | F59L | 0.769 |
| 21:31038267:G:T | F59L | 0.769 |
| 21:31038269:A:G | F59L | 0.769 |
| 21:31038348:G:C | F32L | 0.719 |
| 21:31038348:G:T | F32L | 0.719 |
| 21:31038350:A:G | F32L | 0.719 |
| 21:31038258:G:C | F62L | 0.707 |
| 21:31038258:G:T | F62L | 0.707 |
| 21:31038260:A:G | F62L | 0.707 |
| 21:31038351:G:C | S31R | 0.610 |
| 21:31038351:G:T | S31R | 0.610 |
| 21:31038353:T:G | S31R | 0.610 |
| 21:31038306:G:C | F46L | 0.609 |
| 21:31038306:G:T | F46L | 0.609 |
| 21:31038308:A:G | F46L | 0.609 |
| 21:31038390:A:C | F18L | 0.597 |
| 21:31038390:A:T | F18L | 0.597 |
| 21:31038392:A:G | F18L | 0.597 |
dbSNP variants (sampled 300 via entrez): RS1000863412 (21:31039907 A>G), RS1001274767 (21:31039546 A>G), RS1001934747 (21:31037977 A>T), RS1002653323 (21:31040407 A>G), RS1002671794 (21:31037718 G>A), RS1010136698 (21:31039923 G>C), RS1010722826 (21:31039342 T>C), RS1011005855 (21:31039723 G>A), RS1011727180 (21:31038000 T>C), RS1012765200 (21:31038370 T>C,G), RS1013508755 (21:31037913 C>G,T), RS1014608564 (21:31040383 G>A), RS1016013187 (21:31039024 C>A), RS1017881294 (21:31038489 T>A,C), RS1018835726 (21:31040208 C>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.